Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

Stripped-down CV risk score offers insight into cerebrovascular health

A simplified cardiac risk score can identify plaque buildup and silent brain infarctions that could predict a serious stroke, acting as a red flag for patients without a history of CVD or other vascular problems.

Thumbnail

CVS halts all sales of Zantac, store-brand ranitidine

CVS Pharmacy announced Sept. 28 it would be suspending the sales of all Zantac-brand and CVS Health-brand ranitidine products until further notice, pending the results of an FDA investigation.

Thumbnail

Bootleg cannabis pens found to contain vitamin E, pesticides

Tests commissioned by NBC News have revealed that vitamin E—the suspected culprit behind some 800-plus reported cases of vaping-related lung illness—is present in many THC cartridges sold on the black market, alongside other toxicities like pesticides and myclobutanil.

Thumbnail

Exposure to secondhand smoke in childhood increases lifetime risk of AFib

An analysis of the long-running Framingham Heart Study has revealed that exposure to secondhand smoke in childhood increases a person’s lifetime risk of atrial fibrillation.

Thumbnail

Therapeutic shoe improves stroke survivors’ gait, symmetry

A therapeutic shoe designed to improve stroke survivors’ gait and symmetry was successful in a small-scale trial of six patients, according to a study published in the Journal of NeuroEngineering and Rehabilitation.

Thumbnail

Zantac pulled from global markets amid investigation

Drugmaker Novartis is halting the distribution of generic Zantac, or ranitidine, while the drug is investigated for NDMA, a probable human carcinogen.

Thumbnail

‘Alarming’ number of heart infections can be traced back to opioid epidemic

The opioid crisis is to blame for an “alarming” number of cases of infective endocarditis, according to the American Heart Association.

Study finds aspirin beneficial for some without established CVD

A study published in the Annals of Internal Medicine Sept. 17 suggests daily aspirin could result in a net benefit for some people without established CVD, further muddying the debate over whether aspirin is an effective preventive tool for those without heart disease.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.